Estrous synchronization using an intravaginal progesterone device in combination with gnrh or estradiol benzoate characterized by the initial ovarian conditions in Japanese black cows.
Estrous synchronization using a Controlled Internal Drug Releasing device (CIDR) in combination with GnRH or estradiol benzoate (EB) treatment was investigated in Japanese black cows characterized with initial ovarian conditions. A total of 142 cows were allocated to one of four treatments: insertion of CIDR for eight days (Group A: n=34), CIDR with 100 microg of GnRH on d 0 (Group B: n=54, d 0=CIDR insertion), CIDR with GnRH on d 0 and 1 mg of EB on d 10 (Group C: n=20) or CIDR with 2 mg of EB on d 0 and 1 mg of EB on d 9 (Group D: n=34). All cows received 25 mg of PGF(2alpha) on d 7 and blood was collected for progesterone (P4) analysis on d 0, 8, and 21. AI was performed at estrus, but in Group D timed AI was set following a day of EB treatment. Estrus was induced in 141/142 cows, and the majority of which occurred on d 10 and 11 (98 cows, 34 cows). GnRH treatment induced more intermediate ovulation than EB treatment in cows with CL on d 0 (19.0% vs. 0%). Ovulation after CIDR removal was significantly higher in cows with CL on d 0 compared to those without CL (87.0% vs. 71.4%). Group B showed higher conception rates than those combined with Groups C and D where EB was injected after CIDR removal (51.1% vs. 38.9%). Conception had no correlation with either CL existence on d 0 or intermediate ovulation on d 8. P4 concentrations on d 8 were significantly lower compared to those on d 0 or d 21. On d 21 in cows without intermediate ovulation, Group A showed significantly lower P4 concentrations than the other 3 groups. The data suggests that CIDR insertion with PGF(2alpha) treatment is an effective method for estrous synchronization irrespective of initial ovarian conditions, and GnRH treatment at CIDR insertion induces intermediate ovulation and improves the conception rate in Japanese black cows.
Ando
Takaaki
T
Department of Clinical Veterinary Science, Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi 758-8515, Japan.
Kamimura
Shunichi
S
Hamana
Katsumi
K
D000282:Administration, Intravaginal; D000818:Animals; D002417:Cattle / Q000502:physiology*; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004973:Estrus Synchronization / Q000187:drug effects / Q000379:methods*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology*; D007315:Insemination, Artificial / Q000379:methods / Q000662:veterinary*; D007564:Japan; D010053:Ovary / Q000502:physiology; D010062:Ovulation Induction / Q000662:veterinary; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage / Q000494:pharmacology*
D003692:Delayed-Action Preparations; C074283:estradiol 3-benzoate; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D004958:Estradiol